Souhaitez-vous accéder aux communiqués récents ?

AFB Research Reveals Attitudes Toward and Reach of AI with Focus on Disability

Real-world data advances new insights into donor selection, benchmarks for patient infection prevention and comparative outcomes in a modern post-transplant cyclophosphamide (PTCy) era MINNEAPOLIS,...

Kraig Labs (OTCQB: KBLB) significantly expanded its R&D capacity to keep pace with rapid progress of its Project Atlas advanced materials initiative

$1M Donation by Lume Deodorant Founder Marks the Largest Single Gift to Fund Lobular Breast Cancer Research

AIM Institute and CAN Health Network join forces to help  Canadian solutions reach clinicians and patients faster NEW WESTMINSTER, British Columbia, March 19, 2026 (GLOBE NEWSWIRE) -- Royal...

LONDON and NEW YORK, March 19, 2026 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (NASDAQ: OKYO), a clinical-stage biopharmaceutical company developing investigational therapies for the treatment of...

VANCOUVER, British Columbia, March 19, 2026 (GLOBE NEWSWIRE) -- Equity-Insider.com News Commentary — Big money is moving back into biotech. Institutional investors have been writing some of the...

LONDON and NEW YORK, March 19, 2026 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (NASDAQ: OKYO), a clinical-stage biopharmaceutical company developing investigational therapies for the treatment of...

LONDON and NEW YORK, March 19, 2026 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (NASDAQ: OKYO), a clinical-stage biopharmaceutical company developing investigational therapies for the treatment of...

Raanana, Israel, March 17, 2026 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (Nasdaq: PLRZ) (“Polyrizon” or the “Company”), a pre-clinical-stage biotechnology company developing intranasal administrated...